FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2053968909> ?p ?o ?g. }

• W2053968909 endingPage "184" @default.
• W2053968909 startingPage "177" @default.
• W2053968909 abstract "Alzheimer's disease (AD) is a major neurodegenerative disorder in the elderly and is the most common form of dementia. Approved AD drugs like donepezil and memantine provide some cognitive benefits to a subset of patients. However, the cost burden of AD will continue to increase in the absence of more effective drugs that treat its symptoms and ultimately slow its progression or delay or prevent its onset. A substantial number of studies report that 17β-estradiol (E2; estrogen), a potent endogenous feminizing hormone, is neuroprotective. Unfortunately, negative results from the Women's Health Initiative (WHI) and its ancillary Memory Study (WHIMS) have overshadowed the positive data collected over several decades. Importantly, there are a number of reasons why the WHIMS results should not be generalized to less- or non-feminizing estrogens. For the sake of argument, consider “non-hormonal” or non-feminizing estrogens to be worthwhile drug development candidates for AD and other neurodegenerative conditions because they have the potential to retain the positive neuroprotective activities of E2 while reducing the potential complications associated with feminizing hormones. Because the literature comparing estrogenicity of various estrogens is complex and spans multiple decades, we summarize herein the available hormonal comparisons of a common less-feminizing estrogen, 17α-estradiol (17αE2), with E2. 17αE2 is less feminizing than E2 in every published study where reasonable comparisons can be made. One-half of these studies report a difference of two orders of magnitude or greater. In practice, compounds like 17αE2 may prove to be largely non-feminizing at doses to be explored in human clinical trials. Moreover, other novel E2 analogues have been identified that are essentially devoid of feminizing actions. If the positive effects of feminizing estrogens on neurodegeneration prove useful in treating neurodegenerative diseases, less-feminizing and non-feminizing estrogen analogues may be even more effective, safer, and better tolerated. Drug Dev Res 69:177–184, 2008. © 2008 Wiley-Liss, Inc." @default.
• W2053968909 created "2016-06-24" @default.
• W2053968909 creator A5034339374 @default.
• W2053968909 creator A5056991878 @default.
• W2053968909 creator A5083275081 @default.
• W2053968909 date "2008-06-01" @default.
• W2053968909 modified "2023-10-16" @default.
• W2053968909 title "17α-estradiol: a less-feminizing estrogen" @default.
• W2053968909 cites W1556052989 @default.
• W2053968909 cites W160686759 @default.
• W2053968909 cites W1821318981 @default.
• W2053968909 cites W1899159574 @default.
• W2053968909 cites W1946313188 @default.
• W2053968909 cites W1954468845 @default.
• W2053968909 cites W1966503848 @default.
• W2053968909 cites W1970554029 @default.
• W2053968909 cites W1982563188 @default.
• W2053968909 cites W1984638038 @default.
• W2053968909 cites W1990477938 @default.
• W2053968909 cites W1991853902 @default.
• W2053968909 cites W1994904414 @default.
• W2053968909 cites W2002553027 @default.
• W2053968909 cites W2007645945 @default.
• W2053968909 cites W2016456063 @default.
• W2053968909 cites W2024969879 @default.
• W2053968909 cites W2026364452 @default.
• W2053968909 cites W2026580184 @default.
• W2053968909 cites W2029083534 @default.
• W2053968909 cites W2032789452 @default.
• W2053968909 cites W2032910944 @default.
• W2053968909 cites W2036021600 @default.
• W2053968909 cites W2037850947 @default.
• W2053968909 cites W2043091710 @default.
• W2053968909 cites W2044241508 @default.
• W2053968909 cites W2047349398 @default.
• W2053968909 cites W2049970571 @default.
• W2053968909 cites W2051056532 @default.
• W2053968909 cites W2051593763 @default.
• W2053968909 cites W2053300296 @default.
• W2053968909 cites W2060377254 @default.
• W2053968909 cites W2060383249 @default.
• W2053968909 cites W2065880953 @default.
• W2053968909 cites W2066789280 @default.
• W2053968909 cites W2068342223 @default.
• W2053968909 cites W2069156884 @default.
• W2053968909 cites W2071564608 @default.
• W2053968909 cites W2073883348 @default.
• W2053968909 cites W2076821088 @default.
• W2053968909 cites W2077420563 @default.
• W2053968909 cites W2080038460 @default.
• W2053968909 cites W2082462460 @default.
• W2053968909 cites W2083242665 @default.
• W2053968909 cites W2090353237 @default.
• W2053968909 cites W2097562162 @default.
• W2053968909 cites W2115295553 @default.
• W2053968909 cites W2119613568 @default.
• W2053968909 cites W2119740996 @default.
• W2053968909 cites W2124171187 @default.
• W2053968909 cites W2131266318 @default.
• W2053968909 cites W2131722081 @default.
• W2053968909 cites W2134049170 @default.
• W2053968909 cites W2135551891 @default.
• W2053968909 cites W2135730400 @default.
• W2053968909 cites W2135910109 @default.
• W2053968909 cites W2147863922 @default.
• W2053968909 cites W2149207074 @default.
• W2053968909 cites W2150481168 @default.
• W2053968909 cites W2156616501 @default.
• W2053968909 cites W2158768669 @default.
• W2053968909 cites W2161695527 @default.
• W2053968909 cites W2168233886 @default.
• W2053968909 cites W2409523412 @default.
• W2053968909 cites W293171409 @default.
• W2053968909 cites W4234060991 @default.
• W2053968909 cites W4319054133 @default.
• W2053968909 doi "https://doi.org/10.1002/ddr.20244" @default.
• W2053968909 hasPublicationYear "2008" @default.
• W2053968909 type Work @default.
• W2053968909 sameAs 2053968909 @default.
• W2053968909 citedByCount "9" @default.
• W2053968909 countsByYear W20539689092012 @default.
• W2053968909 countsByYear W20539689092014 @default.
• W2053968909 countsByYear W20539689092015 @default.
• W2053968909 countsByYear W20539689092016 @default.
• W2053968909 countsByYear W20539689092018 @default.
• W2053968909 crossrefType "journal-article" @default.
• W2053968909 hasAuthorship W2053968909A5034339374 @default.
• W2053968909 hasAuthorship W2053968909A5056991878 @default.
• W2053968909 hasAuthorship W2053968909A5083275081 @default.
• W2053968909 hasConcept C126322002 @default.
• W2053968909 hasConcept C15744967 @default.
• W2053968909 hasConcept C25498285 @default.
• W2053968909 hasConcept C2777164284 @default.
• W2053968909 hasConcept C2779134260 @default.
• W2053968909 hasConcept C2779279991 @default.
• W2053968909 hasConcept C2779483572 @default.
• W2053968909 hasConcept C2779484449 @default.
• W2053968909 hasConcept C2780159708 @default.

• next